Delving into the Latest Updates on SkyePharma AG with Synapse

The primary objective of the study was to assess the gastric residence time (GRT) of the Soctec capsule after a standardized breakfast. 12 healthy subjects will undergo an initial screening visit. Eligible subjects will undergo the study procedure. The hypothesis is that the GRT of the Soctect Capsule after a standardized breakfast and lunch will be longer compared to literature values reported for a simliar sized capsule.

开始日期2014-09-01

申办/合作机构

SkyePharma AG

[+1]

EUCTR2010-022513-26-DE / Not yet recruitingN/A

Randomised, single-blind, placebo controlled, four-period four-treatment cross-over design, proof of concept study to compare the pharmacodynamic, safety and pharmacokinetics of one single administration of SKP-1052 versus immediate-release terbutaline and placebo tablets in stable Type 1 Diabetes Mellitus Patients

开始日期2011-02-22

申办/合作机构

SkyePharma AG

NCT00747318 / Completed临床3期

A Phase 3, Multicenter, Open-label Continuation Study in Moderate to Severe Asthmatic Subjects Who Completed FlutiForm HFA pMDI Study SKY2028-3-005, Incorporating Amendment 1 and 2

The objective of this study is to assess the long-term safety and efficacy of FlutiForm HFA pMDI 250/10 mcg bid in adolescents and adults with moderate to severe asthma who have completed the study SKY2028-3-005.

开始日期2008-09-01

申办/合作机构

SkyePharma AG

[+1]

100 项与 SkyePharma AG 相关的临床结果

登录后查看更多信息

0 项与 SkyePharma AG 相关的专利（医药）

登录后查看更多信息

3

项与 SkyePharma AG 相关的文献（医药）

Effect of various actuators/nozzles on the in vitro deposition pattern of liquid metered dose inhalers powered by hydrofluorocarbons

作者: Trachslin, E. ; Kraus, H. ; Keller, M.

The effect of the actuator/nozzle geometry on the spray pattern of a selected corticosteroid liquid metered dose inhaler is shown.

Proceedings of the International Symposium on Controlled Release of Bioactive Materials

In vivo evaluation of the influence of the inert barrier layer in support of the Geomatrix drug delivery technology

作者: Shepard, T. ; Rochdi, M. ; Bethke, P. ; Vergnault, G. ; Rehak, J. ; Dragan, C.

The study demonstrated the major impact of the inert support layer on in vivo control of the system's release performance.By comparison with a standard controlled-release tablet, it appears reliable and effective to modulated drug release behavior of a swellable matrix by altering its releasing surface with a suitable inert support layer.

In vitro performance of Jago's dry powder inhaler (prototype Number9), Glaxo's Diskhaler and Astra's Turbuhaler using the Twin Impinger BP 93 as test device

作者: Trachslin, E. ; Gaibrois, U. ; Keller, M.

The dose uniformity (DU) and drug atomization properties of Jago's Dry Powder Inhaler (DPI) are at least equivalent or even superior to the reference DPIs.DU and RF were only slightly affected by the inspiratory flow applied.Thus, Jago's DPI might by an alternative for pulmonary administration of powder blends and soft pellets.

100 项与 SkyePharma AG 相关的药物交易

登录后查看更多信息

100 项与 SkyePharma AG 相关的转化医学

登录后查看更多信息

组织架构

使用我们的机构树数据加速您的研究。

登录

或

查看完整样例数据

管线布局

2024年11月17日管线快照

管线布局中药物为当前组织机构及其子机构作为药物机构进行统计，早期临床1期并入临床1期，临床1/2期并入临床2期，临床2/3期并入临床3期

批准上市

1

其他

登录后查看更多信息

当前项目

药物(靶点)	适应症	全球最高研发状态

非诺贝特 ( PPARα )	高胆固醇血症更多	批准上市
丙酸氟替卡松/富马酸福莫特罗 ( GR x β2-adrenergic receptor )	哮喘更多	无进展